James E. Levine, Chief Financial Officer at Cidara Therapeutics, Inc. (CDTX), bought 30,000 shares at $1.91 ($57K) on 2019-09-24, disclosed to the SEC on 2020-03-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CRDF | BUY | 2021-09-13 | $194K | — | Filing → |
| CDTX | BUY | 2020-11-12 | $201K | — | Filing → |
| VRNM | BUY | 2012-05-16 | $18K | — | Filing → |